SCPH - Scpharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Scpharmaceuticals's activity chart (see below) currently has 46 price targets and 40 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 9.85% with an average time for these price targets to be met of 86.09 days.

Most recent stock forecast was given by CHASE KNICKERBOCKER from CRAIG HALLUM on 26-Aug-2025. First documented stock forecast 11-Dec-2017.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 08-Nov-2023

$6

$0.33 (5.82%)

$12

1 years 1 months 26 days ago
(26-Aug-2025)

0/3 (0%)

$0.47 (8.50%)

Buy Since 11-Oct-2022

$12

1 years 1 months 27 days ago
(25-Aug-2025)

0/5 (0%)

$8.99 (298.67%)

Buy Since 15-Oct-2019

$18

1 years 7 months 2 days ago
(20-Mar-2025)

0/11 (0%)

$15.07 (514.33%)

Buy Since 21-Oct-2022

$13

$7.33 (129.28%)

$16

1 years 10 months 20 days ago
(02-Dec-2024)

0/3 (0%)

$9.29 (250.40%)

Buy Since 30-Nov-2022

$25

$19.33 (340.92%)

$25

1 years 11 months 29 days ago
(23-Oct-2024)

0/3 (0%)

$20.63 (472.08%)

Show more analysts

Please expand the browser size to see the chart

What is SCPH (Scpharmaceuticals) average time for price targets to be met?

On average it took 86 days for the stock forecasts to be reached, with an average price target met ratio of 9.85%.

Which analyst most recently updated their price target on SCPH (Scpharmaceuticals)?

Chase Knickerbocker

Which analyst has the most public recommendations on SCPH (Scpharmaceuticals)?

Chase Knickerbocker works at CRAIG HALLUM and has 4 price targets and 3 ratings on SCPH

Which analyst is the currently most bullish on SCPH (Scpharmaceuticals)?

Ken Cacciatore with the highest potential upside of $19.33

Which analyst is the currently most reserved on SCPH (Scpharmaceuticals)?

Naz Rahman with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?